Tevanate Once Weekly

Tevanate Once Weekly (alendronate sodium monohydrate) is an oral bisphosphonate used to treat and prevent osteoporosis in postmenopausal women and men. This once-weekly formulation supports bone density and reduces fracture risk. Suitable for adults seeking weekly osteoporosis management. Short-term use under medical guidance recommended.

Alendronate sodium monohydrate, the active ingredient in Tevanate Once Weekly, belongs to a class of medications called bisphosphonates. It works by slowing bone loss to help maintain or increase bone density. This medication is commonly prescribed to reduce the risk of fractures in individuals with osteoporosis or low bone mass. It is also used to treat Paget’s disease of bone in some cases.

Tevanate Once Weekly helps support bone strength by reducing the breakdown of bone tissue. Users may notice improved mobility and comfort over time as bone density stabilizes. Some individuals report reduced back pain associated with vertebral fractures when treatment is effective. Regular use as directed is important for maintaining benefits.

Store Tevanate Once Weekly at room temperature away from moisture and heat. Keep out of reach of children and pets. Take the tablet first thing in the morning with a full glass of water at least 30 minutes before eating, drinking, or taking other medications. Do not lie down for at least 30 minutes after taking the dose to reduce the risk of irritation.

Certain medications can interfere with the absorption of alendronate, including antacids, calcium supplements, and some vitamins. Avoid taking other oral medications, food, or beverages (except water) within 30 minutes of taking Tevanate Once Weekly. Some drugs, such as NSAIDs, may increase the risk of stomach irritation when used with alendronate.